D’Angelo, D.; Glieca, S.; Flammini, L.; Bertoni, S.; Bianchera, A.; Quarta, E.; Forbes, B.; Sonvico, F.; Buttini, F.
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases. Pharmaceutics 2026, 18, 684.
https://doi.org/10.3390/pharmaceutics18060684
AMA Style
D’Angelo D, Glieca S, Flammini L, Bertoni S, Bianchera A, Quarta E, Forbes B, Sonvico F, Buttini F.
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases. Pharmaceutics. 2026; 18(6):684.
https://doi.org/10.3390/pharmaceutics18060684
Chicago/Turabian Style
D’Angelo, Davide, Stefania Glieca, Lisa Flammini, Simona Bertoni, Annalisa Bianchera, Eride Quarta, Ben Forbes, Fabio Sonvico, and Francesca Buttini.
2026. "CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases" Pharmaceutics 18, no. 6: 684.
https://doi.org/10.3390/pharmaceutics18060684
APA Style
D’Angelo, D., Glieca, S., Flammini, L., Bertoni, S., Bianchera, A., Quarta, E., Forbes, B., Sonvico, F., & Buttini, F.
(2026). CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory Diseases. Pharmaceutics, 18(6), 684.
https://doi.org/10.3390/pharmaceutics18060684
